NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 4 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
Q3 2025 vs. Q2 2025
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 131 | 137 | +6 |
| Shares | 116.4M | 120.6M | +4.22M (+3.6%) |
| Value | $2.11B | $3.43B | +$1.32B (+62.7%) |
New holders (21)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (15)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Asset Management Americas Inc | 320,804 | $5.81M |
| AXA S.A. | 242,916 | $4.40M |
| First Trust Advisors LP | 131,430 | $2.38M |
| Alps Advisors Inc | 60,551 | $1.10M |
| Exome Asset Management LLC | 36,574 | $662.4K |
| Two Sigma Investments, LP | 28,392 | $514.2K |
| Millennium Management LLC | 27,345 | $495.2K |
| HRT Financial LP | 26,208 | $474.0K |
| Algert Global LLC | 18,140 | $328.5K |
| Prelude Capital Management, LLC | 13,420 | $243.0K |
| Hudson Bay Capital Management LP | 10,739 | $194.5K |
| Caption Management, LLC | 6,000 | $108.7K |
| Kiker Wealth Management, LLC | 2,000 | $36.2K |
| Caitong International Asset Management Co., Ltd | 595 | $10.8K |
| Raymond James Financial Inc | 500 | $9.05K |